David Watson - 27 Sep 2024 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
General Counsel
Signature
David Watson
Issuer symbol
APLS
Transactions as of
27 Sep 2024
Transactions value $
$0
Form type
4
Filing time
30 Sep 2024, 16:15:04 UTC
Previous filing
08 Mar 2024
Next filing
13 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Gift $0 -10,569 -13.1% $0 70,136 27 Sep 2024 Indirect Owner (The David O. Watson Irrevocable Trust of 2023) F1, F2
transaction APLS Common Stock Gift $0 +10,569 +9.86% $0 117,721 27 Sep 2024 Direct F1
holding APLS Common Stock 3,333 27 Sep 2024 Indirect Owner (Custodial Account for Son) F3
holding APLS Common Stock 6,667 27 Sep 2024 Indirect Owner (The Watson Education Trust) F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the distribution for no value of shares from the David O. Watson Irrevocable Trust of 2023 to the direct holdings of the reporting person.
F2 The securities are held by The David O. Watson Irrevocable Trust of 2023. William Zorn is the trustee of The David O. Watson Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The David O. Watson Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
F3 This represents a custodial account held by the reporting person for the sole benefit of his minor son.
F4 The securities are held by The Watson Education Trust (the "Trust"), for which the reporting person serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Trust except to the extent of his pecuniary interest therein.